The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
transtech pharma | 348 |
high point pharmaceuticals | 93 |
vtv therapeutics | 92 |
novo nordisk | 66 |
pfizer | 12 |
vtvx holdings i | 5 |
tonder, janne ejrnaes | 2 |
vtv therapeutice | 2 |
transtekh farma | 1 |
transtech pharm | 1 |
vtv therapeutics | 31 |
transtech pharma | 4 |
vtvx holdings i | 2 |
novo nordisk | 1 |
pfizer | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
use of metformin in combination with a glucokinase activator and compositions comprising… 🛈 | 44 | 2010 |
oxadiazoanthracene compounds for the treatment of diabetes | 39 | 2008 |
substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use t… 🛈 | 32 | 2009 |
heteroaryl-ureas and their use as glucokinase activators | 28 | 2004 |
phenoxy acetic acids as ppar delta activators | 26 | 2005 |
tris(hydroxymethyl)aminomethane salts of a small-molecule glp1r agonist and pharmaceutic… 🛈 | 22 | 2012 |
glucokinase activator compositions for the treatment of diabetes | 21 | 2012 |
treatment of mild and moderate alzheimer's disease | 21 | 2012 |
benzazole derivatives, compositions, and methods of use as b-secretase inhibitors | 20 | 2005 |
substituted imidazole derivatives and their use as ptpase inhibitors | 18 | 2006 |